Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
human trials
CRO
CRO hVIVO inks deal to test RSV drug in human challenge trial
CRO hVIVO inked a $8.2 million deal to run a human challenge test for an undisclosed company's respiratory syncytial virus antiviral drug candidate.
Joseph Keenan
Feb 8, 2023 10:10am
Intellia reveals first-in-human CRISPR gene editing results
Jun 26, 2021 11:15am
U.S. cancer trials still suffering from lack of diversity: report
Aug 22, 2019 7:10am
Medtronic's latest TAVR wins FDA nod
Mar 22, 2017 11:24am
EMA updates first-in-human trial guidance
Nov 16, 2016 12:10pm
